D. Bates
Oncology · 2002–2018
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 24 citations into it
Whom D. Bates trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- R. Weinberg (in Oncology)
Papers from D. Bates's perspective
Ordered by how strongly the researchers D. Bates trusts endorse each paper. Same corpus, a different order for every researcher.
- Molecular mechanisms and clinical applications of angiogenesis (Nature)
- Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. (Cancer Cell)
- The present and future role of microfluidics in biomedical research (Nature)
- Innovation: Metabolomics: the apogee of the omics trilogy (Nature reviews. Molecular cell biology)
- Dissecting tumour pathophysiology using intravital microscopy (Nature Reviews. Cancer)
- Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. (Annual Review of Cell and Developmental Biology)
- Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox‐1 homeobox transcription factor (EMBO Journal)
- Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. (Molecular Therapy)
- The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. (Developmental Biology)
- The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. (Clinical Chemistry)
Their papers
- Hallmarks of alternative splicing in cancer (2014) — 634 citations
- Consensus guidelines for the use and interpretation of angiogenesis assays (2018) — 555 citations
- VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. (2002) — 607 citations